Literature DB >> 28854096

Targeting the Colorectal Cancer Stem Cell.

Jan Paul Medema1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28854096     DOI： 10.1056/NEJMcibr1706541

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.

Authors:  Hang Zheng; Heshu Liu; Huayu Li; Weidong Dou; Jingui Wang; Junling Zhang; Tao Liu; Yingchao Wu; Yucun Liu; Xin Wang
Journal:  Stem Cell Res Ther       Date:  2022-06-09       Impact factor: 8.079

Review 2.  Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges.

Authors:  Francisco Rodríguez; Pablo Caruana; Noa De la Fuente; Pía Español; María Gámez; Josep Balart; Elisa Llurba; Ramón Rovira; Raúl Ruiz; Cristina Martín-Lorente; José Luis Corchero; María Virtudes Céspedes
Journal:  Biomolecules       Date:  2022-06-04

3.  mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.

Authors:  Ji Young Chang; Jae Hyun Kim; Joyeon Kang; Yehyun Park; Soo Jung Park; Jae Hee Cheon; Won Ho Kim; Hoguen Kim; Jae Jun Park; Tae Il Kim
Journal:  Yonsei Med J       Date:  2020-07       Impact factor: 2.759

4.  STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.

Authors:  Chun-Chia Cheng; Po-Nien Liao; Ai-Sheng Ho; Ken-Hong Lim; Jungshan Chang; Ying-Wen Su; Caleb Gon-Shen Chen; Ya-Wen Chiang; Bi-Ling Yang; Huan-Chau Lin; Yu-Cheng Chang; Chun-Chao Chang; Yi-Fang Chang
Journal:  J Biomed Sci       Date:  2018-08-02       Impact factor: 8.410

5.  α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer.

Authors:  Eric A Hanse; Amber N Habowski; Thai Q Tran; Haiqing Li; Mari B Ishak Gabra; Ying Yang; Xazmin H Lowman; Amelia M Ooi; Shu Y Liao; Robert A Edwards; Marian L Waterman; Mei Kong
Journal:  Nat Cancer       Date:  2020-03-20

6.  Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.

Authors:  Lin Ma; Lan Wang; Yating Shan; Muhammad Nafees; Elshoura Ihab; Ruhui Zhang; Fangjun Wang; Wu Yin
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

7.  4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression.

Authors:  Oluwaseun Adebayo Bamodu; Ching-Kuo Yang; Wei-Hong Cheng; David T W Tzeng; Kuang-Tai Kuo; Chun-Chih Huang; Li Deng; Michael Hsiao; Wei-Hwa Lee; Chi-Tai Yeh
Journal:  Cancers (Basel)       Date:  2018-08-10       Impact factor: 6.639

8.  Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer.

Authors:  Junbao Zhang; Ying Ying; Meiqi Li; Maolin Wang; Xiaoyan Huang; Min Jia; Junhui Zeng; Canjie Ma; Yixiang Zhang; Chen Li; Xiaomei Wang; Xing-Sheng Shu
Journal:  Theranostics       Date:  2020-08-08       Impact factor: 11.556

Review 9.  MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.

Authors:  Kenneth Kw To; Christy Ws Tong; Mingxia Wu; William Cs Cho
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

10.  Clinical Significance of Disseminated Pluripotent Tumor Cell Signature Expression in the Bone Marrow from Patients with Colorectal Cancer.

Authors:  Martin Gasser; Mia Kim; Roberta Rehder; Natasha Frank; Markus Frank; Tanja Grimmig; Romana Moench; Carmen Ribas; Bertram Illert; Christoph-Thomas Germer; Andreas Rosenwald; Ana Maria Waaga-Gasser
Journal:  J Cancer Sci Ther       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.